Page last updated: 2024-08-17

cytidine triphosphate and Alopecia Areata

cytidine triphosphate has been researched along with Alopecia Areata in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Braman, V; Bruce, S; Cassella, JV; Colavincenzo, M; Guttman-Yassky, E; Hamilton, C; Kempers, S; King, B; McMichael, A; Mesinkovska, N; Mirmirani, P; Roberts, JL1

Trials

1 trial(s) available for cytidine triphosphate and Alopecia Areata

ArticleYear
Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata.
    Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:2

    Topics: Adult; Alopecia Areata; Cytidine Triphosphate; Humans; Janus Kinase Inhibitors; Pyrimidines; Treatment Outcome

2022